Acadia Healthcare (ACHC) Tops Q4 EPS by 49c, Guidance Misses Consensus

Acadia Healthcare (NASDAQ: ACHC) reported Q4 EPS of $1.13, $0.49 better than the analyst estimate of $0.64. Revenue for the quarter came in at $541.3 million versus the consensus estimate of $748.57 million.

GUIDANCE:

Acadia Healthcare sees FY2021 EPS of $2.20-$2.45, versus the consensus of $2.56. Acadia Healthcare sees FY2021 revenue of $2.23-2.28 billion, versus the consensus of $3.12 billion.

For earnings history and earnings-related data on Acadia Healthcare (ACHC) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Barclays says AI trade is maturing, favors greater diversification
• Vera Bradley (VRA) Tops Q2 EPS by 10c ; Offers Guidance